Search research articles
Contact Us
Filters
Showing results (31-40 of 178) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
Steven M Devine, Neal Flomenberg, David H Vesole, et al.
Infection Control and Hospital Epidemiology
|
February 1, 2007
Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system
Erik R Dubberke, Justin Sadhu, Robert Gatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor
Beth Christian, Weiqiang Zhao, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2008
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
Tanya M Wildes, Kristan M Augustin, Diane Sempek, et al.
Blood
|
August 17, 2006
Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100
Rebecca M Shepherd, Benjamin J Capoccia, Steven M Devine, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Optimal Donor Selection Across Multiple Outcomes For Hematopoietic Stem Cell Transplantation By Bayesian Nonparametric Machine Learning
Rodney A Sparapani, Martin Maiers, Stephen R Spellman, et al.
Transplantation and Cellular Therapy
|
April 8, 2021
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
Jeffery J Auletta, Jen L Novakovich, Gretta L Stritesky, et al.
Journal of Clinical Apheresis
|
December 1, 2023
Validation of Nivestym compared to Neupogen: An NMDP analysis
Joseph Maakaron, Katie Picotte, Kevin Tram, et al.
Plos One
|
July 23, 2011
CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells
Kechang Liu, Bryan A Anthony, Martha M Yearsly, et al.
International Journal of Bone Marrow Research
|
June 3, 2021
Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)
Yvonne A Efebera, Amy S Ruppert, Apollinaire Ngankeu, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 178) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
Steven M Devine, Neal Flomenberg, David H Vesole, et al.
Infection Control and Hospital Epidemiology
|
February 1, 2007
Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system
Erik R Dubberke, Justin Sadhu, Robert Gatti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor
Beth Christian, Weiqiang Zhao, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2008
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
Tanya M Wildes, Kristan M Augustin, Diane Sempek, et al.
Blood
|
August 17, 2006
Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100
Rebecca M Shepherd, Benjamin J Capoccia, Steven M Devine, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Optimal Donor Selection Across Multiple Outcomes For Hematopoietic Stem Cell Transplantation By Bayesian Nonparametric Machine Learning
Rodney A Sparapani, Martin Maiers, Stephen R Spellman, et al.
Transplantation and Cellular Therapy
|
April 8, 2021
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
Jeffery J Auletta, Jen L Novakovich, Gretta L Stritesky, et al.
Journal of Clinical Apheresis
|
December 1, 2023
Validation of Nivestym compared to Neupogen: An NMDP analysis
Joseph Maakaron, Katie Picotte, Kevin Tram, et al.
Plos One
|
July 23, 2011
CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells
Kechang Liu, Bryan A Anthony, Martha M Yearsly, et al.
International Journal of Bone Marrow Research
|
June 3, 2021
Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)
Yvonne A Efebera, Amy S Ruppert, Apollinaire Ngankeu, et al.
Page
of 18